Prognostically unfavorable factors in Hodgkin's disease
Balcárková-Sebánková, H.; Bĕlusa, M.; Marvan, S.; Pejchlová, M.
Ceskoslovenska Pediatrie 39(2): 88-89
1984
ISSN/ISBN: 0069-2328 PMID: 6534525 Document Number: 240627
Document emailed within 1 workday
Related Documents
Sass, T. 1987: Alignment of the impacted maxillary canines under prognostically unfavorable conditions Deutsche Zahnarztliche Zeitschrift 42(3): 174-176Gobbi, P.G.; Pieresca, C.; Cavanna, L.; Corbella, F.; Vallisa, D.; Federico, M.; Formisano, R.; Carotenuto, M.; Merli, F.; Callea, V.; Angrilli, F.; Silingardi, V. 1996: CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. a prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) Haematologica 81(6): 503-512
Li, R.; Li, X.-p.; Li, X.-m.; Wang, G.-s.; Qian, L.; Tao, J.-h.; Ma, Y.; Zhang, H. 2012: Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy Zhonghua Yi Xue Za Zhi 92(33): 2335-2338
Heinz, R.; Pawlicki, M.; Losonczy, H.; Varbiro, M.; Benedek, S.; Konopka, L.; Krc, I.; Brugiatelli, M. 1986: Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. a study of the I.G.C.i Haematologica 71(6): 473-479
Feil, W.; Wunderlich, M.; Kovats, E.; Neuhold, N.; Schemper, M.; Schiessel, R. 1990: Rectal cancer: prognostically relevant factors for the development of local recurrence following radical anterior resection Wiener Klinische Wochenschrift 102(13): 363-369
Specht, L. 1992: Prognostic factors in Hodgkin's disease Danish Medical Bulletin 39(5): 409-422
Dienstbier, Z.; Foltýnová, V.; Hermanská, Z.; Citavý, M.; Beska, F.; Cerný, J.; Hynek, J.; Koutná, J.; Machácek, J.; Zemanová, E. 1986: Prognostic factors in Hodgkin's disease Neoplasma 33(6): 731-735
Kotlarek-Haus, S.; Gabryś, K.; Starzyk, H.; Sciborski, R.; Gałazka, Z. 1982: Interrelationship between several prognostic factors in Hodgkin's disease Archiv für Geschwulstforschung 52(4): 293-301
Tubiana, M.; Attié, E.; Flamant, R.; Gérard-Marchant, R.; Hayat, M. 1971: Prognostic factors in 454 cases of Hodgkin's disease Cancer Research 31(11): 1801-1810
Kanaev, S.V.; Novikov, S.N.; Zhukova, L.A.; Pozharisskiĭ, K.M.; Leenman, E.E.; Gershanovich, M.L. 2001: Risk factors for bone marrow involvement in Hodgkin's disease Voprosy Onkologii 47(1): 39-44
Henry-Amar, M.; Somers, R. 1990: Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease Seminars in Oncology 17(6): 758-768
Balázs, L. 1990: Immunohistology of Hodgkin's disease. use of monoclonal antibodies in the analysis of the pathomorphology of Hodgkin's disease Morphologiai Es Igazsagugyi Orvosi Szemle 30(3): 182-190
Tubiana, M.; van der Werf-Messing, B.; Laugier, A.; Hayat, M.; Henry-Amar, M.; Attie, E.; Leroy, T. 1973: Survival after recurrence: prognostic factors and spread patterns in clinical stages i and Ii of Hodgkin's disease National Cancer Institute Monograph 36: 513-530
Moghe, M.V.; Advani, S.H.; Gangal, S.G. 1983: Effect of circulating soluble inhibitory factors in Hodgkin's disease on the stimulating activity of PHA pulsed lymphocyte lysates Indian Journal of Medical Research 78(Suppl): 88-94
Burns, L.J.; Daniels, K.A.; McGlave, P.B.; Miller, W.J.; Ramsay, N.K.; Kersey, J.H.; Weisdorf, D.J. 1995: Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival Bone Marrow Transplantation 16(1): 13-18
Aeberhard, P.; Schröder, R.; Joss, J. 1981: Staging laparotomy in Hodgkin's disease and non-Hodgkin lymphomas: indication, technic and results Therapeutische Umschau. Revue Therapeutique 38(9): 875-880
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6